Recurrence of ovarian squamous cell carcinoma with MET gene copy number variation: a case report and review of literature

J Ovarian Res. 2020 May 31;13(1):62. doi: 10.1186/s13048-020-00659-y.

Abstract

Background: Malignant transformation such as ovarian squamous cell carcinoma (SCC) in ovarian mature cystic teratoma (OMCT) is a rare tumor. The gene mutation of ovarian SCC remains unclear. We herein report a recurrent case of ovarian squamous cell carcinoma with MET gene copy number variation.

Case presentation: A 60-year-old woman presented with recurrence of ovarian SCC 8 months after primary surgery. Adhesiolysis, right abdominal wall mass excision, prosthetics, enterectomy, enterostomy and partial cystectomy were performed by laparoscope. Pathologic examination demonstrated metastatic squamous cell carcinoma in ileocecus, rectum and abdominal wall muscle. MET gene copy number was elevated with copy number of six in this case. Postoperatively, the patient was treated with four cycles of combination chemotherapy with docetaxel and carboplatin. The patient was free of disease at 20 months' follow-up.

Conclusions: Optimal cytoreductive surgery combined with platinum-based chemotherapy is recommended currently for not only primary tumor but also recurrence. For patients with malignant transformation in OMCT, prompt diagnosis and individualized treatment are crucial for better prognosis. Increased copy number of MET may be correlated with her poor PFS and can be a potential therapeutic target for this case.

Keywords: Copy number variation; MET gene; Optimal cytoreductive surgery; Ovarian squamous cell carcinoma; Recurrence.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Carcinoma, Ovarian Epithelial / genetics*
  • Carcinoma, Squamous Cell / genetics*
  • DNA Copy Number Variations
  • Female
  • Humans
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Risk Factors